Literature DB >> 21144834

Synemin down-regulation in human hepatocellular carcinoma does not destabilize cytoskeletons in vivo.

Yi-Hsiang Liu1, Chiung-Chi Cheng, Yih-Shyong Lai, Wei-Ting Chao, Ren-Jeng Pei, Yung-Hsiang Hsu, Chin-Chin Ho.   

Abstract

Synemin is a large intermediate filament protein that has been identified in all types of muscle cells. It plays a role in human muscle diseases; however, the role of synemin in tumor cell transformation has rarely been investigated. Because hepatocellular carcinoma cells are morphologically different from normal human hepatocytes, we hypothesized that altered synemin expression and cytoskeletal disorganization might underlie this pleomorphic transformation. To test this hypothesis, we studied synemin expression in hepatocellular carcinoma and liver tissues by immunohistochemistry and immunoblotting. In addition, we analyzed the expression level and organization of all cytoskeletal elements after synemin knock-down in human Chang liver cells. Previously we found that plectin knock-down in human Chang liver cells causes a reduction in cytokeratin 18 expression with effects on intermediate filament disorganization and altered cellular morphology. In this study we also compared the effects of synemin knock-down and plectin knock-down on the cytoskeleton expression and organization. The results revealed that synemin expression was down-regulated in human hepatocellular carcinoma compared with normal liver, which is similar to the plectin expression. Surprisingly, the expression of cytoskeletal elements (cytokeratin 18, actin and tubulin) was not influenced by synemin knock-down in human Chang liver cells. The organization of cytoskeletal networks was also unaltered after synemin knock-down. In conclusion, both plectin and synemin are down-regulated in human hepatocellular carcinoma in vivo and transformed human liver cell in vitro. However, the mechanism of cell transformation caused by synemin knock-down is different from that of plectin knock-down. Plectin, but not synemin, knock-down provoked liver cell transformation via suppressing cytokeratin 18 expression and disrupting intermediate filament networks. Synemin knock-down did not influence the cytoskeleton expression and organization of human Chang liver cells. Copyright Â
© 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21144834     DOI: 10.1016/j.bbrc.2010.12.008

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

Review 1.  The attributes of plakins in cancer and disease: perspectives on ovarian cancer progression, chemoresistance and recurrence.

Authors:  Tamsin Wesley; Stuart Berzins; George Kannourakis; Nuzhat Ahmed
Journal:  Cell Commun Signal       Date:  2021-05-17       Impact factor: 5.712

2.  The Intermediate Filament Synemin Regulates Non-Homologous End Joining in an ATM-Dependent Manner.

Authors:  Sara Sofia Deville; Anne Vehlow; Sarah Förster; Ellen Dickreuter; Kerstin Borgmann; Nils Cordes
Journal:  Cancers (Basel)       Date:  2020-06-28       Impact factor: 6.639

3.  Identification of hub genes in bladder cancer based on weighted gene co-expression network analysis from TCGA database.

Authors:  Lei Wang; Xudong Liu; Miao Yue; Zhe Liu; Yu Zhang; Ying Ma; Jia Luo; Wuling Li; Jiangshan Bai; Hongmei Yao; Yuxuan Chen; Xiaofeng Li; Dayun Feng; Xinqiang Song
Journal:  Cancer Rep (Hoboken)       Date:  2021-09-20

4.  Plectin protects podocytes from adriamycin-induced apoptosis and F-actin cytoskeletal disruption through the integrin α6β4/FAK/p38 MAPK pathway.

Authors:  Yongliang Ni; Xin Wang; Xiaoxuan Yin; Yan Li; Xigao Liu; Haixin Wang; Xiangjv Liu; Jun Zhang; Haiqing Gao; Benkang Shi; Shaohua Zhao
Journal:  J Cell Mol Med       Date:  2018-09-06       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.